This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giacometti, A.
Right arrow Articles by Scalise, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giacometti, A.
Right arrow Articles by Scalise, G.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2000, p. 1694-1696, Vol. 44, No. 6
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

In Vitro Susceptibility Tests for Cationic Peptides: Comparison of Broth Microdilution Methods for Bacteria That Grow Aerobically

A. Giacometti,* O. Cirioni, F. Barchiesi, M. S. Del Prete, M. Fortuna, F. Caselli, and G. Scalise

Institute of Infectious Diseases and Public Health, University of Ancona, Italy

Received 13 September 1999/Returned for modification 7 January 2000/Accepted 26 February 2000

The in vitro susceptibilities of 90 clinical isolates of gram-positive and gram-negative aerobic bacteria to six cationic peptides, buforin II, cecropin P1, indolicidin, magainin II, nisin, and ranalexin, were evaluated by two broth microdilution methods. The first method was performed according to the procedures outlined by the National Committee for Clinical Laboratory Standards for bacteria that grow aerobically, while the second was performed according to the procedures recently proposed by the R. E. W. Hancock laboratory for testing antimicrobial peptides. Overall, the first method produced MICs two- and fourfold higher than the second method.


* Corresponding author. Mailing address: Clinica delle Malattie Infettive, c/o Azienda Ospedaliera Umberto I, Piazza Cappelli, 1, 60121 Ancona, Italy. Phone: 39 71 5963467. Fax: 39 71 5963468. E-mail: cmalinf{at}popcsi.unian.it.


Antimicrobial Agents and Chemotherapy, June 2000, p. 1694-1696, Vol. 44, No. 6
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Pag, U., Oedenkoven, M., Sass, V., Shai, Y., Shamova, O., Antcheva, N., Tossi, A., Sahl, H.-G. (2008). Analysis of in vitro activities and modes of action of synthetic antimicrobial peptides derived from an {alpha}-helical 'sequence template'. J Antimicrob Chemother 61: 341-352 [Abstract] [Full Text]  
  • Pag, U., Oedenkoven, M., Papo, N., Oren, Z., Shai, Y., Sahl, H.-G. (2004). In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates. J Antimicrob Chemother 53: 230-239 [Abstract] [Full Text]  
  • Giacometti, A., Cirioni, O., Ghiselli, R., Mocchegiani, F., Del Prete, M. S., Viticchi, C., Kamysz, W., Lempicka, E., Saba, V., Scalise, G. (2002). Potential Therapeutic Role of Cationic Peptides in Three Experimental Models of Septic Shock. Antimicrob. Agents Chemother. 46: 2132-2136 [Abstract] [Full Text]  
  • Robey, M., O'Connell, W., Cianciotto, N. P. (2001). Identification of Legionella pneumophila rcp, a pagP-Like Gene That Confers Resistance to Cationic Antimicrobial Peptides and Promotes Intracellular Infection. Infect. Immun. 69: 4276-4286 [Abstract] [Full Text]  
  • Giacometti, A., Cirioni, O., Ghiselli, R., Goffi, L., Mocchegiani, F., Riva, A., Scalise, G., Saba, V. (2000). Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis. J Antimicrob Chemother 46: 751-756 [Abstract] [Full Text]